[Situations where natriuretic peptides may be useful]. [PDF]
Aten Primaria, 2012 Jacob J +4 more
europepmc +1 more source
Consensus document of the management of type 2 diabetes and heart failure: Consejo Interamericano de Falla Cardíaca e Hipertensión Pulmonar (CIFACAH) and Inter-American Society of Cardiology (IASC). [PDF]
Arch Cardiol Mex, 2023 Romero A +10 more
europepmc +1 more source
[The use scenarios of the natriuretic peptides. Reply]. [PDF]
Aten Primaria, 2013 Lobos Bejarano JM +2 more
europepmc +1 more source
[Anatomy-physiology considerations for cardiogenic shock with right ventricular involvement]. [PDF]
Rev Med Inst Mex Seguro Soc, 2023 Santos-Martínez LE +7 more
europepmc +1 more source
[Diagnostic protocol for chronic manifestations of COVID-19]. [PDF]
Medicine (Baltimore), 2022 Llorente BC +3 more
europepmc +1 more source
[Troponin-T and n-terminal pro-brain type natriuretic peptide plasma levels and its relationship with mortality in COVID-19]. [PDF]
Hipertens Riesgo Vasc, 2022 Ghelfi AM +9 more
europepmc +1 more source
[Cardiac progression of systemic light chain amyloidosis]. [PDF]
Arch Peru Cardiol Cir Cardiovasc, 2022 Chango Azanza DX +4 more
europepmc +1 more source
[Role of the cardiologist in the management of oncology patients. Where are we standing, and what to expect in the future?] [PDF]
Arch Peru Cardiol Cir Cardiovasc, 2021 Paredes-Paucar C, López-Fernández T.
europepmc +1 more source
[Heart Failure With Preserved Ejection Fraction: A Problem Of Contemporary Cardiology]. [PDF]
Arch Peru Cardiol Cir Cardiovasc, 2020 Saldarriaga-Giraldo C +5 more
europepmc +1 more source
[Diuretic resistance and heart failure: between congestion and kidney injury]. [PDF]
Arch Peru Cardiol Cir Cardiovasc, 2023 Morejón Barragán P.
europepmc +1 more source